Plasma nevirapine levels, adverse events and efficacy of antiretroviral therapy among HIV-infected patients concurrently receiving nevirapine-based antiretroviral therapy and fluconazole

BACKGROUND: The clinical data of plasma NVP level, safety and efficacy of antiretroviral therapy (ART) for the concurrent use of nevirapine (NVP)-based ART and fluconazole (FLU) is scanty. METHODS: A retrospective study was conducted in patients who were initiated NVP-based ART between October 2004...

Descripción completa

Detalles Bibliográficos
Autores principales: Manosuthi, Weerawat, Athichathanabadi, Chatiya, Uttayamakul, Sumonmal, Phoorisri, Thanongsri, Sungkanuparph, Somnuek
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1828732/
https://www.ncbi.nlm.nih.gov/pubmed/17352798
http://dx.doi.org/10.1186/1471-2334-7-14

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1828732/
https://www.ncbi.nlm.nih.gov/pubmed/17352798
http://dx.doi.org/10.1186/1471-2334-7-14

Ejemplares similares